As more markets introduce pathways to support innovative medical devices, regulatory acceleration alone is not enough to ensure timely patient access. APACMed’s position paper compares innovative pathways across selected APAC and reference markets, highlighting practical approaches to eligibility, regulatory support, evidence generation, HTA and funding. It also sets out recommendations to strengthen coordination across the access journey and help innovative technologies reach patients sooner.


